Mozart Therapeutics
PrivateLast Round
Series A
Extension
Jun 7, 2023
Total Funding Raised
$80M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mozart Therapeutics is a biotechnology company that develops disease-modifying therapies for autoimmune and inflammatory diseases by targeting the CD8 T regulatory cell network.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mozart Therapeutics Comparables
Compare Mozart Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GentiBio | 87% | |
| Quell Therapeutics | 86% | |
| Avotres Inc. | 84% | |
Mozart Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 7, 2023 | ||||
| Series A | Oct 26, 2021 |
Mozart Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altitude Life Science Ventures | Series A, Series A Extension |
| ARCH Venture Partners | Series A Extension, Series A |
| ARCH Venture Partners | Series A Extension, Series A, Seed |
| AbbVie Ventures | Series A Extension |
| Alexandria Venture Investments | Series A, Series A Extension |
| Pfizer Ventures | Series A Extension |
| Sofinnova Partners | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Presented interim Phase Ib results at the Immunology of Diabetes Society Congress.
- Apr 23, 2026
Positive interim Phase Ib results for MTX-101 in type 1 diabetes patients.
Mozart Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mozart Therapeutics's valuation, stock price, and market status.